OBIO
OBIO
NASDAQ · Health Care

Orchestra Biomed Holdings In

$4.26
-0.23 (-5.12%)
As of Mar 29, 10:34 PM ET ·
Financial Highlights (FY 2026)
Revenue
4.12M
Net Income
-95,292,114
Gross Margin
92.3%
Profit Margin
-2,313.3%
Rev Growth
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 92.3% 52.2% 52.2% 52.2%
Operating Margin -2,437.5% 14.5% 14.7% 14.2%
Profit Margin -2,313.3% 15.4% 15.8% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.12M 68.62M 71.19M 67.09M
Gross Profit 3.80M 35.85M 37.19M 35.05M
Operating Income -100,348,684 9.92M 10.44M 9.52M
Net Income -95,292,114 10.58M 11.27M 10.19M
Gross Margin 92.3% 52.2% 52.2% 52.2%
Operating Margin -2,437.5% 14.5% 14.7% 14.2%
Profit Margin -2,313.3% 15.4% 15.8% 15.2%
Rev Growth -5.8% -4.6% -3.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 38.00M 31.41M 32.93M 31.53M
Total Equity 87.64M 72.86M 78.63M 70.41M
D/E Ratio 0.43 0.43 0.42 0.45
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -99,943,735 14.36M 13.60M 15.28M
Free Cash Flow 6.20M 6.53M 6.19M